Photosensitizing capabilities of Photofrin® in vascular endothelial cells

C. J. Chang, S. F. Ma, F. C. Wei

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) using Photofrin® (porfimer sodium), an United States Food and Drug Administration approved photosensitizer. The in vitro absorption and photosensitizing activities of Photofrin® were evaluated with cultured human microvascular endothelial cells and in vivo activities were evaluated with ductal carcinoma cell stimulated mammary tumor. The viability of microvascular endothelial cells was assessed using rhodamine-phallodin coupled α-tubulin antibody specific for cytoplasmic microtubule and visualized by immunofluorescence microscopy. At the optimal wavelength of 630 nm, the percentage of microvascular endothelial cells killed by variable concentrations of Photofrin® was measured by either live/dead or lactate dehydrogenase-released assays and the in vivo biological activity was assessed by determining the amount of necrosis produced in stimulated mammary tumor. A combination of 3.5 μg/mL Photofrin® and laser light at 630 nm with a power density of 100 mW/cm2 resulted in a 50% cell kill. The lactate dehydrogenase released from microvascular endothelial cells after PDT showed a 50% optical density obtained from each concentration of photosensitizer of 50% cell killing after laser illumination. Stained histology specimens of stimulated mammary tumor demonstrated significant vascular destruction 1 hour after PDT. In conclusion, Photofrin® has the capabilities to destroy microvascular endothelial cells in vitro and vasculature in vivo. However, the degree of absorption and tissue destruction in vasculature in vivo and different anatomical structures should be considered and will be included in our subsequent studies.

Original languageEnglish
Pages (from-to)287-293
Number of pages7
JournalFormosan Journal of Surgery
Volume34
Issue number6
Publication statusPublished - Jan 1 2001
Externally publishedYes

Fingerprint

Dihematoporphyrin Ether
Endothelial Cells
Photochemotherapy
Photosensitizing Agents
Breast Neoplasms
L-Lactate Dehydrogenase
Lasers
Ductal Carcinoma
Rhodamines
United States Food and Drug Administration
Tubulin
Lighting
Fluorescence Microscopy
Microtubules
Blood Vessels
Histology
Necrosis
Light
Antibodies

Keywords

  • Chicken combs
  • Microvascular endothelial cell
  • Photofrin®

ASJC Scopus subject areas

  • Surgery

Cite this

Photosensitizing capabilities of Photofrin® in vascular endothelial cells. / Chang, C. J.; Ma, S. F.; Wei, F. C.

In: Formosan Journal of Surgery, Vol. 34, No. 6, 01.01.2001, p. 287-293.

Research output: Contribution to journalArticle

@article{0746204f4da74ec3aa5c4d6b5990808b,
title = "Photosensitizing capabilities of Photofrin{\circledR} in vascular endothelial cells",
abstract = "The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) using Photofrin{\circledR} (porfimer sodium), an United States Food and Drug Administration approved photosensitizer. The in vitro absorption and photosensitizing activities of Photofrin{\circledR} were evaluated with cultured human microvascular endothelial cells and in vivo activities were evaluated with ductal carcinoma cell stimulated mammary tumor. The viability of microvascular endothelial cells was assessed using rhodamine-phallodin coupled α-tubulin antibody specific for cytoplasmic microtubule and visualized by immunofluorescence microscopy. At the optimal wavelength of 630 nm, the percentage of microvascular endothelial cells killed by variable concentrations of Photofrin{\circledR} was measured by either live/dead or lactate dehydrogenase-released assays and the in vivo biological activity was assessed by determining the amount of necrosis produced in stimulated mammary tumor. A combination of 3.5 μg/mL Photofrin{\circledR} and laser light at 630 nm with a power density of 100 mW/cm2 resulted in a 50{\%} cell kill. The lactate dehydrogenase released from microvascular endothelial cells after PDT showed a 50{\%} optical density obtained from each concentration of photosensitizer of 50{\%} cell killing after laser illumination. Stained histology specimens of stimulated mammary tumor demonstrated significant vascular destruction 1 hour after PDT. In conclusion, Photofrin{\circledR} has the capabilities to destroy microvascular endothelial cells in vitro and vasculature in vivo. However, the degree of absorption and tissue destruction in vasculature in vivo and different anatomical structures should be considered and will be included in our subsequent studies.",
keywords = "Chicken combs, Microvascular endothelial cell, Photofrin{\circledR}",
author = "Chang, {C. J.} and Ma, {S. F.} and Wei, {F. C.}",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "287--293",
journal = "Formosan Journal of Surgery",
issn = "1011-6788",
publisher = "臺灣外科醫學會",
number = "6",

}

TY - JOUR

T1 - Photosensitizing capabilities of Photofrin® in vascular endothelial cells

AU - Chang, C. J.

AU - Ma, S. F.

AU - Wei, F. C.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) using Photofrin® (porfimer sodium), an United States Food and Drug Administration approved photosensitizer. The in vitro absorption and photosensitizing activities of Photofrin® were evaluated with cultured human microvascular endothelial cells and in vivo activities were evaluated with ductal carcinoma cell stimulated mammary tumor. The viability of microvascular endothelial cells was assessed using rhodamine-phallodin coupled α-tubulin antibody specific for cytoplasmic microtubule and visualized by immunofluorescence microscopy. At the optimal wavelength of 630 nm, the percentage of microvascular endothelial cells killed by variable concentrations of Photofrin® was measured by either live/dead or lactate dehydrogenase-released assays and the in vivo biological activity was assessed by determining the amount of necrosis produced in stimulated mammary tumor. A combination of 3.5 μg/mL Photofrin® and laser light at 630 nm with a power density of 100 mW/cm2 resulted in a 50% cell kill. The lactate dehydrogenase released from microvascular endothelial cells after PDT showed a 50% optical density obtained from each concentration of photosensitizer of 50% cell killing after laser illumination. Stained histology specimens of stimulated mammary tumor demonstrated significant vascular destruction 1 hour after PDT. In conclusion, Photofrin® has the capabilities to destroy microvascular endothelial cells in vitro and vasculature in vivo. However, the degree of absorption and tissue destruction in vasculature in vivo and different anatomical structures should be considered and will be included in our subsequent studies.

AB - The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) using Photofrin® (porfimer sodium), an United States Food and Drug Administration approved photosensitizer. The in vitro absorption and photosensitizing activities of Photofrin® were evaluated with cultured human microvascular endothelial cells and in vivo activities were evaluated with ductal carcinoma cell stimulated mammary tumor. The viability of microvascular endothelial cells was assessed using rhodamine-phallodin coupled α-tubulin antibody specific for cytoplasmic microtubule and visualized by immunofluorescence microscopy. At the optimal wavelength of 630 nm, the percentage of microvascular endothelial cells killed by variable concentrations of Photofrin® was measured by either live/dead or lactate dehydrogenase-released assays and the in vivo biological activity was assessed by determining the amount of necrosis produced in stimulated mammary tumor. A combination of 3.5 μg/mL Photofrin® and laser light at 630 nm with a power density of 100 mW/cm2 resulted in a 50% cell kill. The lactate dehydrogenase released from microvascular endothelial cells after PDT showed a 50% optical density obtained from each concentration of photosensitizer of 50% cell killing after laser illumination. Stained histology specimens of stimulated mammary tumor demonstrated significant vascular destruction 1 hour after PDT. In conclusion, Photofrin® has the capabilities to destroy microvascular endothelial cells in vitro and vasculature in vivo. However, the degree of absorption and tissue destruction in vasculature in vivo and different anatomical structures should be considered and will be included in our subsequent studies.

KW - Chicken combs

KW - Microvascular endothelial cell

KW - Photofrin®

UR - http://www.scopus.com/inward/record.url?scp=0035669743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035669743&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035669743

VL - 34

SP - 287

EP - 293

JO - Formosan Journal of Surgery

JF - Formosan Journal of Surgery

SN - 1011-6788

IS - 6

ER -